Zobrazeno 1 - 10
of 150
pro vyhledávání: '"Gonzalo, Recondo"'
Autor:
Juan Carlos Laguna, Miguel García-Pardo, Joao Alessi, Carlos Barrios, Navneet Singh, Humaid O. Al-Shamsi, Herbert Loong, Miquel Ferriol, Gonzalo Recondo, Laura Mezquita
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 16 (2024)
Lung cancer poses a global health challenge and stands as the leading cause of cancer-related deaths worldwide. However, its incidence, mortality, and characteristics are not uniform across all regions worldwide. Understanding the factors contributin
Externí odkaz:
https://doaj.org/article/e7e80dee28a84ad0826987713fd09406
Publikováno v:
Drugs in Context, Vol 11, Pp 1-10 (2022)
Several oncogenic mechanisms have been identified for MET, including MET amplification, fusions, mutations in the tyrosine kinase domain and exon 14 skipping alterations. MET exon 14 mutations are found in about 3–5% of non-small-cell lung cancers.
Externí odkaz:
https://doaj.org/article/86b1a3368b4b4be5a196449c194588c2
Autor:
Claudio Martin, Gonzalo Recondo, Javier Roberti, Ezequiel García Elorrio, Mònica Castro, Diego Kaen, Iris Boyeras, Mariana Seijo, Verónica Suárez, José Luis Morero, Ana Karina Patané, Sebastián Lamot, Ricardo Re, Artemio García, Patricia Vujacich, Alejandro Videla, Alfonso Fernández-Pazos, Gustavo Lyons, Hugo Paladini, Sergio Benítez, Sebastián Defranchi, Lisandro Paganini, Silvia Quadrelli, Sebastián Rossini, Edgardo Sobrino
Publikováno v:
BMJ Open, Vol 13, Iss 2 (2023)
Background Lung cancer (LC) screening improves LC survival; the best screening method in terms of improving survival is low-dose CT (LDCT), outpacing chest X-ray and sputum cytology.Methods A consensus of experts in Argentina was carried out to revie
Externí odkaz:
https://doaj.org/article/0ec45a0822b1451aa2b5512c3ad097d6
Autor:
Luis E. Raez, Oscar Arrieta, Diego F. Chamorro, Pamela Denisse Soberanis-Piña, Luis Corrales, Claudio Martín, Mauricio Cuello, Suraj Samtani, Gonzalo Recondo, Luis Mas, Zyanya Lucia Zatarain-Barrón, Alejandro Ruíz-Patiño, Juan Esteban García-Robledo, Camila Ordoñez-Reyes, Elvira Jaller, Franco Dickson, Leonardo Rojas, Christian Rolfo, Rafael Rosell, Andrés F. Cardona
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
ObjectivesTo compare the rate disparity between outcomes (overall survival (OS), progression-free survival (PFS), and safety) of concurrent chemoradiation (cCRT) followed by durvalumab in two patient cohorts with locally advanced (LA) stage III non-s
Externí odkaz:
https://doaj.org/article/c84305030f604b3e8a12ead0a3148edf
Autor:
Alejandro Ruiz-Patiño, Oscar Arrieta, Luis E. Pino, Christian Rolfo, Luisa Ricaurte, Gonzalo Recondo, Zyanya-Lucia Zatarain-Barron, Luis Corrales, Claudio Martín, Feliciano Barrón, Carlos Vargas, Hernán Carranza, Jorge Otero, July Rodriguez, Carolina Sotelo, Lucia Viola, Alessandro Russo, Rafael Rosell, Andrés F. Cardona
Publikováno v:
JCO Global Oncology, Vol , Iss 6, Pp 752-760 (2020)
PURPOSE In the midst of a global pandemic, evidence suggests that similar to other severe respiratory viral infections, patients with cancer are at higher risk of becoming infected by COVID-19 and have a poorer prognosis. METHODS We have modeled the
Externí odkaz:
https://doaj.org/article/190fa5ee9d6a40a7a6e1a4e4cdef9392
Autor:
Alejandro Ruiz‐Patiño, Feliciano Barrón, Andrés F. Cardona, Luis Corrales, Luis Mas, Claudio Martín, Zyanya L. Zatarain‐Barrón, Gonzalo Recondo, Luisa Ricaurte, Leonardo Rojas, Pilar Archila, July Rodríguez, Carolina Sotelo, Lucia Viola, Carlos Vargas, Hernán Carranza, Jorge Otero, Luis E. Pino, Christian Rolfo, Rafael Rosell, Oscar Arrieta, The CLICaP
Publikováno v:
Thoracic Cancer, Vol 11, Iss 9, Pp 2552-2560 (2020)
Background The intestinal microbiota is an important factor in modulating immune‐mediated tumor cell destruction. Alterations in the microbiome composition have been linked to reduced efficacy of immune checkpoint inhibitor (ICI) therapies. Therefo
Externí odkaz:
https://doaj.org/article/e1816c0c556f4d82a0133d98cf0baf9e
Autor:
Alejandro Ruiz-Patiño, July Rodríguez, Andrés F. Cardona, Jenny Ávila, Pilar Archila, Hernán Carranza, Carlos Vargas, Jorge Otero, Oscar Arrieta, Lucia Zatarain-Barrón, Carolina Sotelo, Camila Ordoñez, Juan Esteban García-Robledo, Leonardo Rojas, Maritza Bermúdez, Tatiana Gámez, Diana Mayorga, Luis Corrales, Claudio Martín, Gonzalo Recondo, Luis Mas, Suraj Samtani, Luisa Ricaurte, Umberto Malapelle, Alessandro Russo, Feliciano Barrón, Nicolas Santoyo, Christian Rolfo, Rafael Rosell
Publikováno v:
Translational Oncology, Vol 15, Iss 1, Pp 101276- (2022)
Background: The KRAS exon 2 p. G12C mutation in patients with lung adenocarcinoma has been increasing in relevance due to the development and effectiveness of new treatment medications. Studies around different populations indicate that regional vari
Externí odkaz:
https://doaj.org/article/dea50884219f4b58aada2eb1e72a93c5
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
KRAS mutations are one of the most prevalent oncogenic alterations in cancer. Until recently, drug development targeting KRAS did not convey clinical benefits to patients. Specific KRASG12C inhibitors, such as sotorasib and adagrasib, have been desig
Externí odkaz:
https://doaj.org/article/49f67d1d0790455e99fe2f5f7e3f7bfe
Autor:
Mark Awad, Gonzalo Recondo, Giuseppe Lamberti, Scott Rodig, Joao Victor Alessi, Victor Vaz, Adriana Barrichello, Yvonne Lin-Liu, Hersh Gupta, Xinan Wang, Andrew Cherniack, Kristen Felt
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/c19039c2b2f343709f753ff67eb72ede
Autor:
Joao V. Alessi, Arielle Elkrief, Biagio Ricciuti, Xinan Wang, Alessio Cortellini, Victor R. Vaz, Giuseppe Lamberti, Rosa L. Frias, Deepti Venkatraman, Claudia A.M. Fulgenzi, Federica Pecci, Gonzalo Recondo, Alessandro Di Federico, Adriana Barrichello, Hyesun Park, Mizuki Nishino, Grace M. Hambelton, Jacklynn V. Egger, Marc Ladanyi, Subba Digumarthy, Bruce E. Johnson, David C. Christiani, Xihong Lin, Justin F. Gainor, Jessica J. Lin, David J. Pinato, Adam J. Schoenfeld, Mark M. Awad
Publikováno v:
Journal of Thoracic Oncology. 18:731-743
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::356c243e352512e0daaaecb0919e16e9
https://doi.org/10.1016/j.jtho.2023.01.091
https://doi.org/10.1016/j.jtho.2023.01.091